| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 30 |
| 1 | INFLIXIMAB | 26 |
| 2 | ACETAMINOPHEN | 20 |
| 3 | USTEKINUMAB | 18 |
| 4 | ACETAMINOPHEN 500MG | 16 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 16 |
| 6 | PAIN RELIEVER | 16 |
| 7 | ERGOCALCIFEROL | 14 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE | 13 |
| 9 | FOLIC ACID | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-AXXQ | 3 | 0.0026 |
| 1 | INFLIXIMAB-DYYB | 8 | 0.0023 |
| 2 | IBUPROFEN LYSINE | 1 | 0.0018 |
| 3 | DEXTROMETHORPHAN POLISTIREX | 1 | 0.0013 |
| 4 | DISOPYRAMIDE PHOSPHATE | 1 | 0.0012 |
| 5 | DARUNAVIR ETHANOLATE AND COBICISTAT | 2 | 0.0011 |
| 6 | NIRSEVIMAB | 2 | 0.0011 |
| 7 | IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) | 5 | 0.0011 |
| 8 | NIROGACESTAT | 1 | 0.0011 |
| 9 | CROMOLYN SODIUM | 4 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 56 |
| 1 | Corticosteroid [EPC] | 35 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 33 |
| 3 | Interleukin-23 Antagonist [EPC] | 23 |
| 4 | Interleukin-12 Antagonist [EPC] | 18 |
| 5 | Aminosalicylate [EPC] | 14 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 14 |
| 7 | Catecholamine [EPC] | 14 |
| 8 | Provitamin D2 Compound [EPC] | 14 |
| 9 | Vitamin B12 [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 2 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 2 | 0.0011 |
| 3 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 4 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 5 | Human Immunoglobulin G [EPC] | 11 | 0.0005 |
| 6 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 7 | Progestin Antagonist [EPC] | 2 | 0.0004 |
| 8 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 9 | Interleukin-17A Antagonist [EPC] | 9 | 0.0002 |